Breast Neoplasm - Breast Cancer (Invasive)
NCT00520975
Clinical Trial Information
Trial Number: NCT00520975 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"A Randomized Phase III Double-Blind Placebo-Controlled Trial of First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab for Patients With HER-2/NEU Over-Expressing Metastatic Breast Cancer"
Study ID:
E1105
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT01674140
Clinical Trial Information
Trial Number: NCT01674140 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer"
Study ID:
S1207
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT01953588
Clinical Trial Information
Trial Number: NCT01953588 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study"
Study ID:
A011106
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT02927249
Clinical Trial Information
Trial Number: NCT02927249 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial"
Study ID:
A011502
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT00856492
Clinical Trial Information
Trial Number: NCT00856492 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"A Randomized Phase II Trial of Weekly Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel) (NSC-736631) With or Without Bevacizumab, Either Preceded by or Followed by Q 2 Week Doxorubicin (A)and Cyclophosphamide (C) Plus Pegfilgrastim (PEG-G) as Neoadjuvant Therapy For Inflammatory and Locally Advanced HER-2/NEU Negative Breast Cancer"
Study ID:
S0800
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT00376597
Clinical Trial Information
Trial Number: NCT00376597 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer
Study ID:
CALGB-70305
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT01101438
Clinical Trial Information
Trial Number: NCT01101438 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
Study ID:
NCIC-MA.32
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT01242800
Clinical Trial Information
Trial Number: NCT01242800 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Study ID:
E2108
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01242800-D3 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D3, contains longitudinal data on patient-reported outcomes. Dataset NCT01242800-D1 contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. |
| NCT01242800-D2 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. Dataset NCT01242800-D1 contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D3 contains longitudinal data on patient-reported outcomes. |
| NCT01242800-D1 | There are three submissions for PMID 34995128. This dataset, NCT01242800-D1, contains patient characteristics, disease status, and efficacy data at step 1. Dataset NCT01242800-D2 contains disease status, treatment, and efficacy data at step 2. Dataset NCT01242800-D3 contains longitudinal data on patient-reported outcomes. |
NCT01272037
Clinical Trial Information
Trial Number: NCT01272037 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A PHASE III, RANDOMIZED CLINICAL TRIAL OF STANDARD ADJUVANT ENDOCRINE THERAPY+/- CHEMOTHERAPY IN PATIENTS WITH 1-3 POSITIVE NODES, HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCERWITH RECURRENCE SCORE (RS) OF 25 OR LESS. RXPONDER: A CLINICAL TRIAL RX FORPOSITIVE NODE, ENDOCRINE RESPONSIVE BREAST CANCER
Study ID:
S1007
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT00075764
Clinical Trial Information
Trial Number: NCT00075764 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
Study ID:
S0226
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®